• 1
    Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996; 91: 95962.
  • 2
    Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19(Suppl. 1): S3743.
  • 3
    Kohmoto K, Haruma K, Kamada T, et al. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998; 93: 12716.
    Direct Link:
  • 4
    Haruma K, Komoto K, Kamada T, et al. Helicobacter pylori is a major risk factor for gastric carcinoma in young patients. Scand J Gastroenterol 2000; 35: 2559.
  • 5
    Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 7849.
  • 6
    Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 63942.
  • 7
    Sasaki A, Haruma K, Kitadai Y, et al. Influence of Helicobacter pylori infection on cell proliferation of gastric cancer (Abstract). In: XIVth International Workshop on Gastrointestinal Pathology and Helicobacter pylori, Strasbourg, 2001. Gur 2001; 49(Suppl. 2): A59.
  • 8
    Song YH, Ma JY, Mardh S, et al. Localization of a pernicious anemia autoantibody epitope on the alpha-subunit of human H,K-adenosine triphosphatase. Scand J Gastroenterol 1994; 29: 1227.
  • 9
    Ma JY, Borch K, Mardh S. Human gastric H,K-adenosine triphosphatase beta-subunit is a major autoantigen in atrophic corpus gastritis. Scand J Gastroenterol 1994; 29: 7904.
  • 10
    Karlsson FA, Burman P, Loof L, Mardh S. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach. J Clin Invest 1988; 81: 4759.
  • 11
    Claeys D, Faller G, Appelmelk BJ, Negrini R, Kirchner T. The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998; 115: 3407.
  • 12
    Faller G, Steininger H, Kranzlein J, et al. Antigastric autoantibodies in Helicobacter pylori infection: Implications of histological and clinical parameters of gastritis. Gut 1997; 41: 61923.
  • 13
    Faller G, Winter M, Steininger H, Konturek P, Konturek SJ, Kirchner T. Antigastric autoantibodies and gastric secretory function in Helicobacter pylori-infected patients with duodenal ulcer and non-ulcer dyspepsia. Scand J Gastroenterol 1998; 33: 27682.
  • 14
    Ito M, Haruma K, Kaya S, et al. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis. Evaluation in a country of high prevalence of atrophic gastritis. Scand J Gastroenterol 2002; 37: 28793.
  • 15
    Ito M, Haruma K, Kaya S, et al. Serologic comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients. Eur J Gastroenterol Hepatol 2002; 14: 1237.
  • 16
    Haruma K, Ito M, Kido S, et al. Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis. Dig Dis Sci 2002; 47: 8627.
  • 17
    Haruma K, Komoto K, Kawaguchi H, et al. Pernicious anemia and Helicobacter pylori infection in Japan: Evaluation in a country with a high prevalence of infection. Am J Gastroenterol 1995; 90: 110710.
  • 18
    Dixon MF, Genta RM, Yardley JH, Correa P and the participants in the International Workshop on the Histopathology of Gastritis, Houston, 1994. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis. Am J Surg Pathol 1996; 20: 116181.
  • 19
    Yoshihara M, Sumii K, Haruma K, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93: 10906.
    Direct Link:
  • 20
    Sachs G, Chang HH, Rabon E, Schackman R, Lewin M, Saccomani G. A nonelectrogenic H+ pump in plasma membranes of hog stomach. J Biol Chem 1976; 251: 76908.
  • 21
    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 1976; 72: 24854.
  • 22
    Karlsson FA, Burman P, Loof L, Olsson M, Scheynius A, Mardh S. Enzyme-linked immunosorbent assay of H+,K+-ATPase, the parietal cell antigen. Clin Exp Immunol 1987; 70: 60410.
  • 23
    Haruma K, Mihara M, Kamada T, et al. Eradication of Helicobacter pylori reverses intestinal metaplasia in patients with severe atrophic gastritis. Gastroenterology 1997; 112: A142(Abstract).
  • 24
    Annibale B, Aprile MR, D'ambra G, et al. Cure of Helicobacter pylori infection in atrophic body gastritis does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000; 14: 62534.DOI: 10.1046/j.1365-2036.2000.00752.x
  • 25
    Sung JJY, Lin SR, Ching JYL, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective randomized study. Gastroenterology 2000; 119: 714.
  • 26
    Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement of atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 3806.
  • 27
    Kokkola A, Sipponen P, Rautelin H, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dyspepsia. Aliment Pharmacol Ther 2002; 16: 51520.
  • 28
    Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus. Evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999; 13: 15562.
  • 29
    D'elios M, Bergman MP, Azzurri A, et al. H+,K+-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 2001; 120: 37786.
  • 30
    Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83: 2049.
  • 31
    Kekki M, Samloff IM, Varis K, Ihamaki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991; 26(Suppl. 186): 10916.
  • 32
    Nakamura M, Haruma K, Kamada T, et al. Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects. Dig Dis Sci 2002; 47: 67581.
  • 33
    Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 1996; 23: 30715.
  • 34
    Satoh K, Kimura K, Takimoto T, et al. A follow up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998; 3: 23640.
  • 35
    Hattori T. Development of adenocarcinomas in the stomach. Cancer 1986; 57: 152834.